Data available regarding patient perspectives on ulcerative colitis and their preferences and satisfaction with therapy are limited.
Dr Gray and colleagues from Canada examined the preferences of ulcerative colitis patients to understand better what they look for in a therapy when managing their disease, as this may influence overall medication adherence.
The team reported tha the study surveyed 100 Canadian ulcerative colitis patients on topics including educational resources used to learn about the disease.
The team also surveyed the patients on medication attributes that are most valued and preferred by the patient and satisfaction with current therapy.
|Ulcerative colitis patients rated speed of symptom relief|
|Alimentary Pharmacology & Therapeutics.|
The researchers found overall, efficacy and safety related medication attributes were rated by patients to be more important than those related to dosing regimen, cost and formulary coverage.
In pair-wise comparisons of specific medication attributes, ulcerative colitis patients rated speed of symptom relief and few side effects as the most important factors when considering a ulcerative colitis medication.
Dr Gray's team concluded, “This study provides insight into ulcerative colitis patient preferences and satisfaction with therapy that may be important when counselling on treatment options, and generates relevant discussions on adherence.”
“Larger studies may be warranted to examine further how these findings can be extrapolated to broader ulcerative colitis populations.”